Table 5.

All statements about the relative importance of undertaking appropriate evaluation, in descending order of average strength of agreement

	% rating very or extremely important	Mean rating*
Use quantitative data to measure if trade-offs, pleasant and/or unpleasant surprises have occurred	90†	4.48
Use data (eg, qualitative, quantitative, already available or bespoke) to make evaluative judgements/measure trade-offs, pleasant and/or unpleasant surprises with the same rigour as measuring improvement goals	88†	4.45
Use qualitative data to make evaluative judgements about the presence and extent of trade-offs, pleasant and/or unpleasant surprises	86†	4.41
Use bespoke data collection by clinical teams to measure trade-offs, pleasant and/or unpleasant surprises	46	4.13
Use data that is already collected for another purpose to measure trade-offs, pleasant and/or unpleasant surprises	41	4.05

*1=not at all important, 2=slightly important, 3=somewhat important, 4=very important, 5=extremely important.

†Indicates consensus among panellists meaning that ≥80% of participants rated a statement as very important and extremely important.